Lucid Diagnostics Inc（LUCD）價格預測LUCDLucid Diagnostics Inc

Alphio's LUCD stock price prediction model matches the current Lucid Diagnostics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.41 (-1.34%). The 1-week path is $0.41 (-0.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Lucid Diagnostics Inc is a good buy right now, primarily due to its recent announcement of receiving Medicare payments for its EsoGuard test at $1,938.01 per test, which could significantly enhance revenue streams. The stock has shown a remarkable recovery with a 25.42% increase yesterday, despite a 5-day decline of 14.02%. The current price is $0.41, which is significantly below the analyst price target of $3, indicating a potential upside of over 600%. However, the main risk is the company's ongoing net losses, with a reported net income loss of $23,628,000 in Q2 2026, which could impact future performance if not addressed.

Lucid Diagnostics Inc (LUCD) last closed at $0.411, gaining +25.42%. These facts feed the 1-day and 1-week LUCD price prediction above.